Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023473 (
chronic myeloid leukemia
)
18,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PDCD5
(programmed cell death 5) accelerates apoptosis of certain tumor cells and is expressed at low levels in marrow-nucleated cells of AML and
CML
patients. In the present study, we evaluated the effects of
PDCD5
overexpression on drug sensitivity of leukemia cells. K562 cells were treated with idarubicin (IDR) alone or in combination with adenoviral vectors expressing
PDCD5
(Ad-PDCD5). As shown by annexin-V-FITC/PI dual labeling, apoptosis rates were markedly increased after combined treatment with Ad-
PDCD5
compared to IDR treatment alone. We observed that
PDCD5
overexpression significantly improves the antitumor effects of low dose IDR treatment in vivo. Tumor sizes were significantly decreased in combined Ad-
PDCD5
and low dose IDR treatment groups compared with single IDR treatment groups. Similar results were obtained with combined systemic treatment of Ad-
PDCD5
and low dose IDR, and combined treatment with Ad-
PDCD5
local injection and low dose IDR i.p. injection. These results indicate that Ad-
PDCD5
may be a promising agent for enhancing chemosensitivity.
...
PMID:Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo. 1840 19
PDCD5
(programmed cell death 5) is an apoptosis related gene cloned in 1999 from a human leukemic cell line.
PDCD5
protein containing 125 amino acid (aa) residues sharing significant homology to the corresponding proteins of species. Decreased expression of
PDCD5
has been found in many human tumors, including breast, gastric cancer, astrocytic glioma,
chronic myelogenous leukemia
and hepatocellular carcinoma. In recent years, increased number of studies have shown the functions and mechanisms of
PDCD5
protein in cancer cells, such as paraptosis, cell cycle and immunoregulation. In the present review, we provide a comprehensive review on the role of
PDCD5
in cancer tissues and cells. This review summarizes the recent studies of the roles of
PDCD5
in inflammation and cancer. We mainly focus on discoveries related to molecular mechanisms of
PDCD5
protein. We also discuss some discrepancies between the current studies. Overall, the current available data will open new perspectives for a better understanding of
PDCD5
in cancer.
...
PMID:Roles of programmed cell death protein 5 in inflammation and cancer (Review). 2782 15